Search for pathway correlated target
You are searching for: hsa04022
T29500 Target Info |
Target Name | Adrenergic receptor alpha-1B (ADRA1B) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Attention deficit hyperactivity disorder; Hypertension; | ||
Drugs | Propericiazine | Drug Info |
T53381 Target Info |
Target Name | Adrenergic receptor alpha-1D (ADRA1D) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Glaucoma/ocular hypertension; Congestive heart failure; | ||
Drugs | Alfuzosin | Drug Info |
T82841 Target Info |
Target Name | Insulin (INS) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Measure kidney function; Malaria; | ||
Drugs | Insulin determir | Drug Info |
T68461 Target Info |
Target Name | Adenine nucleotide translocator 1 (SLC25A4) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Hypercalcaemia; | ||
Drugs | Clodronate | Drug Info |
T71230 Target Info |
Target Name | Atrial natriuretic peptide receptor A (NPR1) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Acute heart failure; Asthma; | ||
Drugs | Nesiritide | Drug Info |
T51282 Target Info |
Target Name | Rho-associated protein kinase 1 (ROCK1) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Open-angle glaucoma; Diabetic nephropathy; | ||
Drugs | Netarsudil | Drug Info |
T35940 Target Info |
Target Name | ERK activator kinase 1 (MEK1) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Melanoma; Thyroid cancer; | ||
Drugs | Selumetinib | Drug Info |
T67619 Target Info |
Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Triple negative breast cancer; Colorectal cancer; | ||
Drugs | Capivasertib | Drug Info |
T36059 Target Info |
Target Name | Adenosine A3 receptor (ADORA3) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Psoriasis vulgaris; Solid tumour/cancer; | ||
Drugs | IB-MECA | Drug Info |
T89055 Target Info |
Target Name | ERK activator kinase 2 (MEK2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Melanoma; Thyroid cancer; | ||
Drugs | Selumetinib | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.